Stock Report

Download full stock data and analysis for free Last Updated: 06-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

West Pharmaceutical Services (WST) Key Ratios

Stock Card factsheet share-fund-plan-icon

$397.19

up-down-arrow $-11.59 (-2.84%)

As on 05-Nov-2026 14:44EST

Market cap

info icon

$29,323 Mln

Revenue (TTM)

info icon

$3,397 Mln

P/E Ratio

info icon

53.4

P/B Ratio

info icon

9.5

Div. Yield

info icon

0.2 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.25 8.73 12.58 5.10 4.84
EBIT 49.47 53.76 29.03 5.46 2.56
Net Profit 38.96 52.86 29.94 4.53 0.85
EPS 39.94 56.96 32.46 6.36 2.01
Book Value -- -- 20.03 7.15 12.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 21.2622.8723.0619.4920.34
Net Margin info --21.8318.81----
Return on equity info 18.6322.1621.4416.8517.71
Return on Capital info 16.7119.63--15.0115.95
Return on Assets info 13.8716.0413.5312.4813.19
Debt to Equity (x) info ----0.070.130.11

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
15.01
15.95
19.16
20.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

21.44

Higher than Peers by 16.26

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
21.44
16.85
17.71
21.32
23.34
Peer Median
5.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

13.53

Higher than Peers by 10.89

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
13.53
12.48
13.19
15.94
16.91
Peer Median
2.63
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

23.06

Higher than Peers by 14.14

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
23.06
19.49
20.34
23.95
23.83
Peer Median
8.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

18.81

Higher than Peers by 13.50

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
18.81
16.06
17.03
20.11
20.49
Peer Median
5.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

12.58

Higher than Peers by 3.32

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
12.58
0.06
-0.02
0.02
0.02
Peer Median
9.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

29.03

Higher than Peers by 15.66

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
29.03
1.84
-16.75
2.81
-9.23
Peer Median
13.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

29.94

Higher than Peers by 14.17

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
29.94
0.20
-16.97
1.28
-11.47
Peer Median
15.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

32.46

Higher than Peers by 9.41

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
32.46
0.02
-0.16
0.02
-0.11
Peer Median
23.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-0.12

Lower than Peers by 7.81

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
-0.12
--
--
--
--
Peer Median
7.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.07

Lower than Peers by 0.29

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
0.07
0.13
0.11
0.11
0.12
Peer Median
0.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
0.01
0.01
0.01
0.05
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.82

Lower than Peers by 0.05

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
2.82
3.02
2.79
2.88
3.70
Peer Median
2.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.10

Lower than Peers by 0.00

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
2.10
2.34
2.11
2.24
2.90
Peer Median
2.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

59.33

Higher than Peers by 54.10

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
59.33
998.67
202.90
80.32
90.46
Peer Median
5.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

22.03

Higher than Peers by 5.59

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
22.03
18.69
19.10
17.35
17.58
Peer Median
16.44
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.72

Higher than Peers by 0.21

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
0.72
0.78
0.77
0.79
0.83
Peer Median
0.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
66.96
67.21
63.08
63.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
76.08
78.41
85.32
82.94
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
45.69
46.53
45.98
46.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
--
97.35
99.08
102.42
99.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

53.35

Higher than Peers by 6.18

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
53.35
40.52
49.00
44.50
30.37
Peer Median
47.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

9.50

Higher than Peers by 5.05

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
9.50
6.30
9.00
9.17
6.63
Peer Median
4.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.22

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
0.22
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

32.16

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
32.16
25.47
32.22
30.64
21.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

29,323

Higher than Peers by 28,724

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
West Pharmaceutical Services (WST)
29,323
--
--
--
--
Peer Median
599
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds